Jazz Pharmaceuti (JAZZ)
$122.92
0.00 (0.00%)
JAZZ Stock Quote Delayed 30 Minutes
The 3 Best Cannabis Stocks to Buy in August 2024
Although cannabis stocks have been brutalized earlier, favorable legal winds could make the sector intriguing again.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$126.40
Market Cap
7.68B
PE Ratio
14.48
EPS
8.4869
Volume (Avg. Vol.)
1.69M
Day's Range
$122.83 - $126.90
52-Week Range
$99.06 - $148.06
Dividend & Yield
N/A (N/A)
JAZZ Stock Predictions, Articles, and Jazz Pharmaceuti News
7 Biotech Stocks to Boost Your Portfolio to Peak Health
With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas.
3 Cannabis Stocks That Could Make Your Grandchildren Rich
These cannabis stocks offer long-term growth potential anchored by solid operational models and diversified revenue streams today.
JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
JAZZ stock results show that Jazz Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
